Investor Relations | Newsroom
Corporate Profile
Biodesix is a leading data-driven diagnostic solutions company leveraging state of the art technologies with our proprietary artificial intelligence platform to discover, develop, and commercialize solutions for clinical unmet needs, with a primary focus in lung disease. We strive to be a trusted partner that the world relies on for diagnostic solutions in lung disease by improving overall patient outcomes and lowering the overall healthcare cost by reducing the use of ineffective and unnecessary treatments and procedures.
Biodesix is covered by the following analysts:
TD Cowen
Lake Street
Lake Street
William Blair
Canaccord Genuity
Canaccord Genuity
Craig-Hallum
Scotiabank
Scotiabank
Minimum 15 minutes delayed. Source:
News Releases
Events
Nov 21, 2024 at 1:00 PM EST
Nov 20, 2024
Nov 19, 2024